Antidepressant Tablet Franchise in Ahmedabad

Dothiepin 25 mg Tablet Supplier in Mumbai

Psychiatry Tablet Distributor in Delhi

Mental Health Pharma Franchise in Bangalore

Antidepressant Tablet Stockist in Hyderabad
Psychiatry Tablet Manufacturer & Exporter in Chandigarh

Home/Products /dothiepin-25-mg-tablet

Dothprime 25 Tablet

Composition : Dothiepin (25 mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹0/-

Dothprime 25 Tablet contains Dothiepin 25 mg, a tricyclic antidepressant used for the treatment of depressive disorders and anxiety-related conditions. It helps in improving mood, emotional stability, and overall mental health.

Dothiepin works by balancing neurotransmitters such as serotonin and norepinephrine in the brain, which play a key role in regulating mood and emotional responses. This action helps reduce symptoms of depression, anxiety, and associated sleep disturbances.

Clinically, Dothprime 25 Tablet is prescribed in depression, anxiety disorders, psychosomatic conditions, and chronic emotional stress, offering reliable therapeutic response and patient compliance when used as directed.

From a portfolio perspective, Dothprime 25 Tablet strengthens the psychiatry and mental health therapy segment, with consistent demand across psychiatric clinics, hospitals, and general practice settings, supporting long-term prescription continuity.

Read More

About the Product

Dothprime 25 Tablet contains Dothiepin 25 mg, a tricyclic antidepressant used for the treatment of depressive disorders and anxiety-related conditions. It helps in improving mood, emotional stability, and overall mental health.

Dothiepin works by balancing neurotransmitters such as serotonin and norepinephrine in the brain, which play a key role in regulating mood and emotional responses. This action helps reduce symptoms of depression, anxiety, and associated sleep disturbances.

Clinically, Dothprime 25 Tablet is prescribed in depression, anxiety disorders, psychosomatic conditions, and chronic emotional stress, offering reliable therapeutic response and patient compliance when used as directed.

From a portfolio perspective, Dothprime 25 Tablet strengthens the psychiatry and mental health therapy segment, with consistent demand across psychiatric clinics, hospitals, and general practice settings, supporting long-term prescription continuity.

Common side effects may include dry mouth, drowsiness, dizziness, constipation, blurred vision, and weight gain. Rarely, cardiac rhythm disturbances, confusion, or allergic reactions may occur, especially in elderly patients.

Dothprime 25 Tablet is indicated for the treatment of depressive disorders, anxiety states, and associated insomnia. It may also be used in certain cases of chronic pain or psychosomatic disorders, as prescribed by a psychiatrist or physician.

Use Dothprime 25 Tablet strictly under medical supervision. Avoid alcohol while taking this medicine. Inform your doctor if you have a history of heart disease, glaucoma, urinary retention, or epilepsy. Do not stop the medication abruptly without consulting your physician.

Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children. Do not use beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation